Erech Finance Cahalacha EFNC-M.TA · ILA

Its shares trade on Tel Aviv under the ticker EFNC-M.TA. It has been listed since 4 August 2010. In the fiscal year to 31 December 2024, it reported revenue of ILS 181,000 and a net loss of ILS 8.3m. At that date it held total assets of ILS 16.7m and shareholders' equity of −ILS 2.5m.

Erech Finance Cahalacha Ltd. engages in the provision of non-bank credit, and research and development of medical equipment and medicines. As of August 2011, Insuline Medical Ltd's product line included the InsuPatch device for insulin pump users, which includes disposable InsuPatch set for three days use and an InsuPatch pump adaptor that includes rechargeable battery and electronics; and the InsuPad device for injection users, which includes a disposable pad for one day use, a rechargeable battery and electronics as well as a carrying case. On January 2011, Insuline Medical Ltd established a fully owned subsidiary in Germany, InsuLine Medical GmBH.

Figures and description from our data supplier, not checked against the company's own report.

• Mr. Eliyahu NaorChairman of the Board, since 2018
• Mr. Yosef WassermanCo-Chief Executive Officer, Director, since 2018
• Mr. David GerbiVice President - Finance
• Mr. Yisrael GewirtzInternal Auditor
• Mr. Avinoam Ben NunDirector, since 2018
• Mr. Ziv EisnerDirector
• Mr. Avraham SarfatyDirector, since 2017
• Mr. Michael KenigExternal Director
• Ms. Sharon TeperbergExternal Director

Overall

0

Environment

0

Social

0

Governance

0

Data on this tab

Our data supplier

Chart on the Overview

TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.